Presently, Marc Schegerin occupies the position of Chief Operating & Financial Officer at Morphic Holding, Inc. and Chief Financial & Operating Officer at Morphic Therapeutic, Inc. (a subsidiary of Morphic Holding, Inc.). Dr. Schegerin is also on the board of SQZ Biotechnologies Co.

In the past Dr. Schegerin was Treasurer, Chief Financial Officer & Head-Strategy at ArQule, Inc.

Dr. Schegerin received a doctorate from Dartmouth Medical School, an MBA from Tuck School of Business at Dartmouth and an undergraduate degree from Tulane University (Louisiana).